Check out this new release of the OSP CYP3A4-DDI qualification report, where Pharmetheus in partnership with Boehringer Ingelheim contributed by adding a perpetrator contributed by adding a perpetrator (fluconazole) with 3 victims (alfentanil, midazolam and triazolam)!
